Title : Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway.

Pub. Date : 2020 Jun 1

PMID : 31960922






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway. Doxorubicin AKT serine/threonine kinase 1 Homo sapiens
2 RSK4 may effectively attenuate DOX resistance in BC by inhibiting the PI3K/AKT signalling pathway. Doxorubicin AKT serine/threonine kinase 1 Homo sapiens